Long-term tracking and population characteristics of lipoprotein (a) in the Cardiovascular Risk in Young Finns Study

dc.contributor.authorRaitakari Olli
dc.contributor.authorKivelä Annukka
dc.contributor.authorPahkala Katja
dc.contributor.authorRovio Suvi
dc.contributor.authorMykkänen Juha
dc.contributor.authorAhola-Olli Ari
dc.contributor.authorLoo Britt-Marie
dc.contributor.authorLyytikäinen Leo-Pekka
dc.contributor.authorLehtimäki Terho
dc.contributor.authorKähönen Mika
dc.contributor.authorJuonala Markus
dc.contributor.authorRönnemaa Tapani
dc.contributor.authorLamina Claudia
dc.contributor.authorKronenberg Florian
dc.contributor.authorViikari Jorma
dc.contributor.organizationfi=InFLAMES Lippulaiva|en=InFLAMES Flagship|
dc.contributor.organizationfi=kliininen kemia|en=Clinical Chemistry|
dc.contributor.organizationfi=kliininen laitos|en=Department of Clinical Medicine|
dc.contributor.organizationfi=sisätautioppi|en=Internal Medicine|
dc.contributor.organizationfi=sydäntutkimuskeskus|en=Cardiovascular Medicine (CAPC)|
dc.contributor.organizationfi=tyks, vsshp|en=tyks, varha|
dc.contributor.organizationfi=väestötutkimuskeskus|en=Centre for Population Health Research (POP Centre)|
dc.contributor.organization-code1.2.246.10.2458963.20.35734063924
dc.contributor.organization-code1.2.246.10.2458963.20.40502528769
dc.contributor.organization-code1.2.246.10.2458963.20.42471027641
dc.contributor.organization-code1.2.246.10.2458963.20.61334543354
dc.contributor.organization-code1.2.246.10.2458963.20.68445910604
dc.contributor.organization-code1.2.246.10.2458963.20.93148683050
dc.contributor.organization-code2607008
dc.converis.publication-id176212883
dc.converis.urlhttps://research.utu.fi/converis/portal/Publication/176212883
dc.date.accessioned2022-10-28T13:15:23Z
dc.date.available2022-10-28T13:15:23Z
dc.description.abstract<p>Background and aims</p><p>Lipoprotein (a) (Lp(a)) is a causal risk factor for cardiovascular diseases and its levels are under strict genetic control. Therefore, it is hypothesized that the concentration of Lp(a) remains stable throughout life. Finns have lower Lp(a) levels than central Europeans, but it is unknown whether there are differences within Finland, especially between the eastern and western parts of the country with known genetic duality and persistent differences in cardiovascular disease rates. We have examined the long-term stability of Lp(a) levels over 25 years in the Cardiovascular Risk in Young Finns Study (YFS), and the characteristics of individuals with different Lp(a) levels, including their geographical origin within Finland.<br></p><p>Methods</p><p>In YFS, the first large baseline examination was conducted in 1980 (baseline age, 3–18 years). Several follow-ups during the past 40 years have been conducted to investigate the determinants of cardiometabolic health. Lp(a) levels have been measured in study years 1986 (N = 2464, ages 9–24 years), 2001 (N = 2281, ages 24–39 years), 2007 (N = 2204, ages 35–45 years) and 2011 (N = 2044, ages 39–49 years). Tracking of Lp(a) was estimated by calculating Spearman's rank order correlations between the study years, and by cross-tabulating how many individuals diagnosed with either elevated or non-elevated Lp(a) levels in 1986, 2001 and 2007 remained in the same category in the latest follow-up in 2011.<br></p><p>Results</p><p>Spearman's correlation coefficients varied between r = 0.84–0.96. Most individuals (87–94%) who had a high Lp(a) level (>30 mg/dl) in any of the previous study years had a high level also in 2011. On average, the median Lp(a) levels were consistently ∼20% higher in the individuals originating from eastern Finland compared to those from western Finland, but there were no differences in the distribution of known genetic determinants between eastern and western Finns that would have explained the observed difference.<br></p><p>Conclusions</p><p>These data confirm that Lp(a) levels remain very stable over the life-course. In line with the genetic duality between eastern and western parts of Finland, we observed about 20% higher Lp(a) levels in individuals originating from eastern Finland compared to those originating from western Finland.</p>
dc.format.pagerange18
dc.format.pagerange27
dc.identifier.eissn1879-1484
dc.identifier.jour-issn0021-9150
dc.identifier.olddbid180845
dc.identifier.oldhandle10024/163939
dc.identifier.urihttps://www.utupub.fi/handle/11111/36144
dc.identifier.urlhttps://doi.org/10.1016/j.atherosclerosis.2022.07.009
dc.identifier.urnURN:NBN:fi-fe2022091258682
dc.language.isoen
dc.okm.affiliatedauthorRaitakari, Olli
dc.okm.affiliatedauthorPahkala, Katja
dc.okm.affiliatedauthorRovio, Suvi
dc.okm.affiliatedauthorMykkänen, Juha
dc.okm.affiliatedauthorAhola-Olli, Ari
dc.okm.affiliatedauthorLoo, Britt-Marie
dc.okm.affiliatedauthorJuonala, Markus
dc.okm.affiliatedauthorRönnemaa, Tapani
dc.okm.affiliatedauthorViikari, Jorma
dc.okm.affiliatedauthorDataimport, tyks, vsshp
dc.okm.discipline3121 Internal medicineen_GB
dc.okm.discipline3142 Public health care science, environmental and occupational healthen_GB
dc.okm.discipline3121 Sisätauditfi_FI
dc.okm.discipline3142 Kansanterveystiede, ympäristö ja työterveysfi_FI
dc.okm.internationalcopublicationinternational co-publication
dc.okm.internationalityInternational publication
dc.okm.typeA1 ScientificArticle
dc.publisherElsevier Ireland Ltd
dc.publisher.countryIrelanden_GB
dc.publisher.countryIrlantifi_FI
dc.publisher.country-codeIE
dc.relation.doi10.1016/j.atherosclerosis.2022.07.009
dc.relation.ispartofjournalAtherosclerosis
dc.relation.volume356
dc.source.identifierhttps://www.utupub.fi/handle/10024/163939
dc.titleLong-term tracking and population characteristics of lipoprotein (a) in the Cardiovascular Risk in Young Finns Study
dc.year.issued2022

Tiedostot

Näytetään 1 - 1 / 1
Ladataan...
Name:
1-s2.0-S0021915022013508-main.pdf
Size:
1.23 MB
Format:
Adobe Portable Document Format